Down-modulation of the CXCR4 co-receptor by intracellular expression of a single chain variable fragment (SFv) inhibits HIV-1 entry into primary human brain microvascular endothelial cells and post-mitotic neurons

Molecular Brain Research

Volumn 135, Issue 1-2, 2005, Pages 48-57

  Mukhtar, Muhammad ^a   Acheampong, Edward ^a   Khan, Muhammad Ayub ^a   Bouhamdan, Mohammed ^a,b   Pomerantz, Roger J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

AIDS dementia complex; CNS; CXCR4; Gene therapy; HIV 1; Single chain antibody

Indexed keywords

BETA GALACTOSIDASE; CHEMOKINE RECEPTOR CXCR4; VIRUS VECTOR;

ARTICLE; BRAIN CELL; BRAIN MICROCIRCULATION; BRAIN NERVE CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL TYPE; CONTROLLED STUDY; ENDOTHELIUM CELL; EXPRESSION VECTOR; GENE CONSTRUCT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOHISTOCHEMISTRY; MITOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 18044388199     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2004.11.015     Document Type: Article

References (61)

1. E.G. Argyris, E. Acheampong, G. Nunnari, M. Mukhtar, K.J. Williams, and R.J. Pomerantz Human immunodeficiency virus type 1 enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid rafts J. Virol. 77 2003 12140 12151
2. M. Baba, O. Nishimura, N. Kanzaki, M. Okamoto, H. Sawada, Y. Iizawa, M. Shiraishi, Y. Aramaki, K. Okonogi, Y. Ogawa, K. Meguro, and M. Fujino A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity Proc. Natl. Acad. Sci. U. S. A. 96 1999 5698 5703
3. D.H. Barouch, J. Kunstman, M.J. Kuroda, J.E. Schmitz, S. Santra, F.W. Peyerl, G.R. Krivulka, K. Beaudry, M.A. Lifton, D.A. Gorgone, D.C. Montefiori, M.G. Lewis, S.M. Wolinsky, and N.L. Letvin Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes Nature 415 2002 335 339
4. A. Borsetti, C. Parolin, B. Ridolfi, L. Sernicola, A. Geraci, B. Ensoli, and F. Titti CD4-independent infection of two CD4(-)/CCR5(-)/CXCR4(+) pre-T-cell lines by human and simian immunodeficiency viruses J. Virol. 74 2000 6689 6694
5. M. BouHamdan, D.S. Strayer, D. Wei, M. Mukhtar, L.X. Duan, J. Hoxie, and R.J. Pomerantz Inhibition of HIV-1 infection by down-regulation of the CXCR4 co-receptor using an intracellular single chain variable fragment against CXCR4 Gene Ther. 8 2001 408 418
6. A. Boutet, H. Salim, Y. Taoufik, P.M. Lledo, J.D. Vincent, J.F. Delfraissy, and M. Tardieu Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4 Glia 34 2001 165 177
7. H. Choe, M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P.D. Ponath, L. Wu, C.R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard, and J. Sodroski The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates Cell 85 1996 1135 1148
8. K.L. Coburn, N.C. Moore, H.P. Katner, K.A. Tucker, W.S. Pritchard, and D.W. Duke HIV and the brain: evidence of early involvement and progressive damage NeuroReport 3 1992 539 541
9. E. De Clercq, and D. Schols Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists Antiviral Chem. Chemother. 12 Suppl. 1 2001 19 31
10. F.S. De Silva, D.S. Venturini, E. Wagner, P.R. Shank, and S. Sharma CD4-independent infection of human B cells with HIV type 1: detection of unintegrated viral DNA AIDS Res. Hum. Retroviruses 17 2001 1585 1598
11. G.A. Donzella, D. Schols, S.W. Lin, J.A. Este, K.A. Nagashima, P.J. Maddon, G.P. Allaway, T.P. Sakmar, G. Henson, E. De Clercq, and J.P. Moore AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor Nat. Med. 4 1998 72 77
12. B.J. Doranz, J. Rucker, Y. Yi, R.J. Smyth, M. Samson, S.C. Peiper, M. Parmentier, R.G. Collman, and R.W. Doms A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2 b as fusion cofactors Cell 85 1996 1149 1158
13. B.J. Doranz, K. Grovit-Ferbas, M.P. Sharron, S.H. Mao, M.B. Goetz, E.S. Daar, R.W. Doms, and W.A. O'Brien A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor J. Exp. Med. 186 1997 1395 1400
14. B.J. Doranz, L.G. Filion, F. Diaz-Mitoma, D.S. Sitar, J. Sahai, F. Baribaud, M.J. Orsini, J.L. Benovic, W. Cameron, and R.W. Doms Safe use of the CXCR4 inhibitor ALX40-4 C in humans AIDS Res. Hum. Retroviruses 17 2001 475 486
15. T. Dragic, V. Litwin, G.P. Allaway, S.R. Martin, Y. Huang, K.A. Nagashima, C. Cayanan, P.J. Maddon, R.A. Koup, J.P. Moore, and W.A. Paxton HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 Nature 381 1996 667 673
16. A.L. Edinger, J.L. Mankowski, B.J. Doranz, B.J. Margulies, B. Lee, J. Rucker, M. Sharron, T.L. Hoffman, J.F. Berson, M.C. Zink, V.M. Hirsch, J.E. Clements, and R.W. Doms CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain Proc. Natl. Acad. Sci. U. S. A. 94 1997 14742 14747
17. A.L. Edinger, T.L. Hoffman, M. Sharron, B. Lee, B. O'Dowd, and R.W. Doms Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins Virology 249 1998 367 378
18. T.G. Edwards, T.L. Hoffman, F. Baribaud, S. Wyss, C.C. LaBranche, J. Romano, J. Adkinson, M. Sharron, J.A. Hoxie, and R.W. Doms Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein J. Virol. 75 2001 5230 5239
19. J.A. Este TAK-779 (Takeda) Curr. Opin. Invest. Drugs 2 2001 354 356
20. N. Fujii, and H. Tamamura Peptide-lead CXCR4 antagonists with high anti-HIV activity Curr. Opin. Invest. Drugs 2 2001 1198 1202
21. D. Gabuzda, J. He, A. Ohagen, and A.V. Vallat Chemokine receptors in HIV-1 infection of the central nervous system Semin. Immunol. 10 1998 203 213
22. S. Ghezzi, S. Menzo, A. Brambilla, P.P. Bordignon, A.L. Lorini, M. Clementi, G. Poli, and E. Vicenzi Inhibition of R5X4 dualtropic HIV-1 primary isolates by single chemokine co-receptor ligands Virology 280 2001 253 261
23. R.G. Gonzalez, L.L. Cheng, S.V. Westmoreland, K.E. Sakaie, L.R. Becerra, P.L. Lee, E. Masliah, and A.A. Lackner Early brain injury in the SIV-macaque model of AIDS AIDS 14 2000 2841 2849
24. P.R. Gorry, G. Bristol, J.A. Zack, K. Ritola, R. Swanstrom, C.J. Birch, J.E. Bell, N. Bannert, K. Crawford, H. Wang, D. Schols, E. De Clercq, K. Kunstman, S.M. Wolinsky, and D. Gabuzda Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity J. Virol. 75 2001 10073 10089
25. P.R. Gorry, J. Taylor, G.H. Holm, A. Mehle, T. Morgan, M. Cayabyab, M. Farzan, H. Wang, J.E. Bell, K. Kunstman, J.P. Moore, S.M. Wolinsky, and D. Gabuzda Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate J. Virol. 76 2002 6277 6292
26. J.M. Harouse, and F. Gonzalez-Scarano Infection of SK-N-MC cells, a CD4-negative neuroblastoma cell line, with primary human immunodeficiency virus type 1 isolates J. Virol. 70 1996 7290 7294
27. J.M. Harouse, C. Kunsch, H.T. Hartle, M.A. Laughlin, J.A. Hoxie, B. Wigdahl, and F. Gonzalez-Scarano CD4-independent infection of human neural cells by human immunodeficiency virus type 1 J. Virol. 63 1989 2527 2533
28. J. Hesselgesser, M. Halks-Miller, V. DelVecchio, S.C. Peiper, J. Hoxie, D.L. Kolson, D. Taub, and R. Horuk CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons Curr. Biol. 7 1997 112 121
29. M.W. Hornef, A. Iten, P. Maeder, J.G. Villemure, and L. Regli Brain biopsy in patients with acquired immunodeficiency syndrome: diagnostic value, clinical performance, and survival time Arch. Intern. Med. 159 1999 2590 2596
30. Y. Huang, W.A. Paxton, S.M. Wolinsky, A.U. Neumann, L. Zhang, T. He, S. Kang, D. Ceradini, Z. Jin, K. Yazdanbakhsh, K. Kunstman, D. Erickson, E. Dragon, N.R. Landau, J. Phair, D.D. Ho, and R.A. Koup The role of a mutant CCR5 allele in HIV-1 transmission and disease progression Nat. Med. 2 1996 1240 1243
31. A.P. Kerza-Kwiatecki, and S. Amini CNS as an HIV-1 reservoir; BBB and drug delivery J. Neurovirol. 5 1999 113 114
32. R.S. Klein, K.C. Williams, X. Alvarez-Hernandez, S. Westmoreland, T. Force, A.A. Lackner, and A.D. Luster Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDS J. Immunol. 163 1999 1636 1646
33. E. Lavi, J.M. Strizki, A.M. Ulrich, W. Zhang, L. Fu, Q. Wang, M. O'Connor, J.A. Hoxie, and F. Gonzalez-Scarano CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons Am. J. Pathol. 151 1997 1035 1042
34. S. Lee, H.L. Tiffany, L. King, P.M. Murphy, H. Golding, and M.B. Zaitseva CCR8 on human thymocytes functions as a human immunodeficiency virus type 1 coreceptor J. Virol. 74 2000 6946 6952
35. R.M. Levy, E. Russell, M. Yungbluth, D.F. Hidvegi, B.A. Brody, and M.C. Dal Canto The efficacy of image-guided stereotactic brain biopsy in neurologically symptomatic acquired immunodeficiency syndrome patients Neurosurgery 30 1992 186 189 (discussion 189-90)
36. J. Martin, C.C. LaBranche, and F. Gonzalez-Scarano Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate J. Virol. 75 2001 3568 3580
37. A. McKnight, D. Wilkinson, G. Simmons, S. Talbot, L. Picard, M. Ahuja, M. Marsh, J.A. Hoxie, and P.R. Clapham Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent J. Virol. 71 1997 1692 1696
38. H. Miyoshi, M. Takahashi, F.H. Gage, and I.M. Verma Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector Proc. Natl. Acad. Sci. U. S. A. 94 1997 10319 10323
39. M. Mukhtar, and R.J. Pomerantz Development of an in vitro blood-brain barrier model to study molecular neuropathogenesis and neurovirologic disorders induced by human immunodeficiency virus type 1 infection J. Hum. Virol. 3 2000 324 334
40. M. Mukhtar, H. Duke, M. BouHamdan, and R.J. Pomerantz Anti-human immunodeficiency virus type 1 gene therapy in human central nervous system-based cells: an initial approach against a potential viral reservoir Hum. Gene Ther. 11 2000 347 359
41. M. Mukhtar, S. Harley, P. Chen, M. BouHamdan, C. Patel, E. Acheampong, and R.J. Pomerantz Primary isolated human brain microvascular endothelial cells express diverse HIV/SIV-associated chemokine coreceptors and DC-SIGN and L-SIGN Virology 297 2002 78 88
42. L. Naldini, U. Blomer, F.H. Gage, D. Trono, and I.M. Verma Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector Proc. Natl. Acad. Sci. U. S. A. 93 1996 11382 11388
43. L. Naldini, U. Blomer, P. Gallay, D. Ory, R. Mulligan, F.H. Gage, I.M. Verma, and D. Trono In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector Science 272 1996 263 267
44. A. Ohagen, A. Devitt, K.J. Kunstman, P.R. Gorry, P.P. Rose, B. Korber, J. Taylor, R. Levy, R.L. Murphy, S.M. Wolinsky, and D. Gabuzda Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS J. Virol. 77 2003 12336 12345
45. C. Pinganaud, and C. Goujard Management of antiretroviral treatment in HIV-infected patients exhibiting virologic failure Presse Med. 31 2002 1034 1040
46. R.J. Pomerantz Residual HIV-1 infection during antiretroviral therapy: the challenge of viral persistence AIDS 15 2001 1201 1211
47. R.J. Pomerantz Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy Biomed. Pharmacother. 55 2001 7 15
48. S. Rana, G. Besson, D.G. Cook, J. Rucker, R.J. Smyth, Y. Yi, J.D. Turner, H.H. Guo, J.G. Du, S.C. Peiper, E. Lavi, M. Samson, F. Libert, C. Liesnard, G. Vassart, R.W. Doms, M. Parmentier, and R.G. Collman Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta CCR5 mutation J. Virol. 71 1997 3219 3227
49. J.D. Reeves, N. Heveker, A. Brelot, M. Alizon, P.R. Clapham, and L. Picard The second extracellular loop of CXCR4 is involved in CD4-independent entry of human immunodeficiency virus type 2 J. Gen. Virol. 79 Pt 7 1998 1793 1799
50. G. Scarlatti, E. Tresoldi, A. Bjorndal, R. Fredriksson, C. Colognesi, H.K. Deng, M.S. Malnati, A. Plebani, A.G. Siccardi, D.R. Littman, E.M. Fenyo, and P. Lusso In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression Nat. Med. 3 1997 1259 1265
51. B. Schramm, M.L. Penn, R.F. Speck, S.Y. Chan, E. De Clercq, D. Schols, R.I. Connor, and M.A. Goldsmith Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease J. Virol. 74 2000 184 192
52. M. Sharron, S. Pohlmann, K. Price, E. Lolis, M. Tsang, F. Kirchhoff, R.W. Doms, and B. Lee Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes Blood 96 2000 41 49
53. J.M. Strizki, J.D. Turner, R.G. Collman, J. Hoxie, and F. Gonzalez-Scarano A monoclonal antibody (12G5) directed against CXCR-4 inhibits infection with the dual-tropic human immunodeficiency virus type 1 isolate HIV-1(89.6) but not the T-tropic isolate HIV-1 (HxB) J. Virol. 71 1997 5678 5683
54. H. Tamamura, A. Omagari, K. Hiramatsu, K. Gotoh, T. Kanamoto, Y. Xu, E. Kodama, M. Matsuoka, T. Hattori, N. Yamamoto, H. Nakashima, A. Otaka, and N. Fujii Development of specific CXCR4 inhibitors possessing high selectivity indexes as well as complete stability in serum based on an anti-HIV peptide T140 Bioorg. Med. Chem. Lett. 11 2001 1897 1902
55. G.D. Tomaras, and M.L. Greenberg Mechanisms for HIV-1 entry: current strategies to interfere with this step Curr. Infect. Dis. Rep. 3 2001 93 99
56. G. Trillo-Pazos, A. Diamanturos, L. Rislove, T. Menza, W. Chao, P. Belem, S. Sadiq, S. Morgello, L. Sharer, and D.J. Volsky Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection Brain Pathol. 13 2003 144 154
57. A.V. Vallat, U. De Girolami, J. He, A. Mhashilkar, W. Marasco, B. Shi, F. Gray, J. Bell, C. Keohane, T.W. Smith, and D. Gabuzda Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS Am. J. Pathol. 152 1998 167 178
58. M. Violin, F. Forbici, A. Cozzi-Lepri, R. Velleca, A. Bertoli, C. Riva, S. Giannella, P.E. Manconi, A. Lazzarin, S. Pasquinucci, L. Tacconi, G. Carnevale, F. Mazzotta, L. Bonazzi, M. Montroni, A. Chirianni, M. Capobianchi, G. Ippolito, M. Moroni, C.F. Perno, and A. D'Arminio-Monforte Primary HIV-1 resistance in recently and chronically infected individuals of the Italian cohort naive for antiretrovirals J. Biol. Regul. Homeostatic Agents 16 2002 37 43
59. S.V. Westmoreland, X. Alvarez, C. deBakker, P. Aye, M.L. Wilson, K.C. Williams, and A.A. Lackner Developmental expression patterns of CCR5 and CXCR4 in the rhesus macaque brain J. Neuroimmunol. 122 2002 146 158
60. B.J. Willett, K. Adema, N. Heveker, A. Brelot, L. Picard, M. Alizon, J.D. Turner, J.A. Hoxie, S. Peiper, J.C. Neil, and M.J. Hosie The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus J. Virol. 72 1998 6475 6481
61. Y. Yi, S.N. Isaacs, D.A. Williams, I. Frank, D. Schols, E. De Clercq, D.L. Kolson, and R.G. Collman Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism J. Virol. 73 1999 7117 7125